ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 201 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $262,090 | -28.8% | 56,976 | 0.0% | 0.44% | +81.9% |
| Q2 2023 | $368,065 | -14.3% | 56,976 | 0.0% | 0.24% | -20.3% |
| Q1 2023 | $429,599 | -25.6% | 56,976 | 0.0% | 0.30% | -84.9% |
| Q4 2022 | $577,167 | +2.5% | 56,976 | 0.0% | 2.02% | +8.9% |
| Q3 2022 | $563,000 | -7.2% | 56,976 | 0.0% | 1.85% | +24.5% |
| Q2 2022 | $607,000 | +55.2% | 56,976 | +42.1% | 1.49% | +120.6% |
| Q1 2022 | $391,000 | -26.6% | 40,091 | +7.6% | 0.67% | +11.6% |
| Q4 2021 | $533,000 | -13.5% | 37,264 | +21.3% | 0.60% | -6.1% |
| Q3 2021 | $616,000 | +11.6% | 30,719 | +22.4% | 0.64% | +2.1% |
| Q2 2021 | $552,000 | -16.1% | 25,107 | +29.6% | 0.63% | -27.9% |
| Q1 2021 | $658,000 | +82.8% | 19,372 | +116.8% | 0.87% | +76.6% |
| Q4 2020 | $360,000 | – | 8,936 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCVC Bio GP, LLC | 29,411 | $313,000 | 100.00% |
| Founders Fund VII Management, LLC | 3,773,530 | $40,188,000 | 93.02% |
| Gruss & Co., LLC | 363,778 | $3,874,000 | 26.99% |
| Founders Fund Growth Management, LLC | 407,017 | $4,334,000 | 12.66% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $44,387,000 | 5.09% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $43,719,000 | 5.06% |
| Intellectus Partners, LLC | 1,089,755 | $11,606,000 | 3.99% |
| ArchPoint Investors | 630,326 | $6,713,000 | 2.66% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $607,000 | 1.49% |
| Orbimed Advisors | 4,180,768 | $44,525,000 | 0.81% |